Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SABRATEK CORP (SBTK) -- Ignore unavailable to you. Want to Upgrade?

To: mod who wrote (381)	8/2/1999 7:26:00 PM
From: Kevin Podsiadlik	Read Replies (1) \| Respond to of 487

While you ponder whether to jump back in (wink wink), you might consider another funny aspect of that Ralin offering. In addition to the maximum of $19M they can get from the sale, there's also a minimum of $16M they're guaranteed to receive, with SBTK making up any deficit. Meaning, as long as there's nothing major to propel this puppy back up above $17 3/4, Ralin doesn't have a particularly huge incentive not to keep on distributing stock.

To: mod who wrote (381)	8/13/1999 11:40:00 AM
From: LTK007	Respond to of 487

mod don't expect you ever to eat your words,but you should. Pluvia glad to see your justification coming forth. <<SKOKIE, Ill., Aug 13 (Reuters) - Sabratek Corp., a medical device maker, said Friday it would delay the release of its second-quarter results pending completion of a review with its independent auditors.>>